Aspirin Is Associated With Reduced Cardiovascular and All-Cause Mortality in Type 2 Diabetes in a Primary Prevention Setting: The Fremantle Diabetes Study

OBJECTIVE: To determine whether regular aspirin use (≥75 mg/day) is independently associated with cardiovascular disease (CVD) and all-cause mortality in community-based patients with type 2 diabetes and no history of CVD. RESEARCH DESIGN AND METHODS: Of the type 2 diabetic patients recruited to the...

Descripción completa

Detalles Bibliográficos
Autores principales: Ong, Greg, Davis, Timothy M.E., Davis, Wendy A.
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2010
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2809273/
https://www.ncbi.nlm.nih.gov/pubmed/19918016
http://dx.doi.org/10.2337/dc09-1701

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2809273/
https://www.ncbi.nlm.nih.gov/pubmed/19918016
http://dx.doi.org/10.2337/dc09-1701

Ejemplares similares